<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0017779"><a href="http://purl.obolibrary.org/obo/MONDO_0017779">MONDO:0017779</a></h3>
<p><strong>Label:</strong> alpha-N-acetylgalactosaminidase deficiency</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0012221">MONDO:0012221</a> (alpha-N-acetylgalactosaminidase deficiency type 1),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_79281">Orphanet:79281</a>, <a href="http://www.orpha.net/ORDO/Orphanet_3137">Orphanet:3137</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609241">OMIM:609241</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79279">Orphanet:79279</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0012067">HP:0012067</a> (Glycopeptiduria) and <a href="http://purl.obolibrary.org/obo/HP_0100704">HP:0100704</a> (Cortical visual impairment) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012067">HP:0012067</a> (Glycopeptiduria) and <a href="http://purl.obolibrary.org/obo/HP_0012795">HP:0012795</a> (Abnormality of the optic disc) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012067">HP:0012067</a> (Glycopeptiduria) and <a href="http://purl.obolibrary.org/obo/HP_0012758">HP:0012758</a> (Neurodevelopmental delay) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010864">HP:0010864</a> (Intellectual disability, severe) and <a href="http://purl.obolibrary.org/obo/HP_0012067">HP:0012067</a> (Glycopeptiduria) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004349">HP:0004349</a> (Reduced bone mineral density) and <a href="http://purl.obolibrary.org/obo/HP_0012067">HP:0012067</a> (Glycopeptiduria) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004348">HP:0004348</a> (Abnormality of bone mineral density) and <a href="http://purl.obolibrary.org/obo/HP_0012067">HP:0012067</a> (Glycopeptiduria) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003700">HP:0003700</a> (Generalized amyotrophy) and <a href="http://purl.obolibrary.org/obo/HP_0012067">HP:0012067</a> (Glycopeptiduria) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003593">HP:0003593</a> (Infantile onset) and <a href="http://purl.obolibrary.org/obo/HP_0012067">HP:0012067</a> (Glycopeptiduria) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0100704">HP:0100704</a> (Cortical visual impairment) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0012795">HP:0012795</a> (Abnormality of the optic disc) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0012758">HP:0012758</a> (Neurodevelopmental delay) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0010864">HP:0010864</a> (Intellectual disability, severe) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0004349">HP:0004349</a> (Reduced bone mineral density) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0004348">HP:0004348</a> (Abnormality of bone mineral density) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0003700">HP:0003700</a> (Generalized amyotrophy) 62.50%</li>
</ul>
</body>
</html>
